These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9328044)

  • 1. Ontogeny of vesicular amine transporter expression in the rat: new perspectives on aminergic neuronal and neuroendocrine differentiation.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Adv Pharmacol; 1998; 42():903-8. PubMed ID: 9328044
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system.
    Schäfer MK; Eiden LE; Weihe E
    Neuroscience; 1998 May; 84(2):331-59. PubMed ID: 9539209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP and NPY expression during differentiation of cholinergic and noradrenergic sympathetic neurons.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Ann N Y Acad Sci; 1998 Dec; 865():537-41. PubMed ID: 9928065
    [No Abstract]   [Full Text] [Related]  

  • 5. The vesicular monoamine transporter VMAT2 and vesicular acetylcholine transporter VAChT are sorted to separate vesicle populations in PC12 cells.
    Tao-Cheng JH; Eiden LE
    Adv Pharmacol; 1998; 42():250-3. PubMed ID: 9327891
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurogenetics of synaptic transmission in Caenorhabditis elegans.
    Rand JB; Duerr JS; Frisby DL
    Adv Pharmacol; 1998; 42():940-4. PubMed ID: 9328053
    [No Abstract]   [Full Text] [Related]  

  • 7. Identified neurons in C. elegans coexpress vesicular transporters for acetylcholine and monoamines.
    Duerr JS; Gaskin J; Rand JB
    Am J Physiol Cell Physiol; 2001 Jun; 280(6):C1616-22. PubMed ID: 11350757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional implications of the noradrenergic-cholinergic switch induced by retinoic acid in NB69 neuroblastoma cells.
    Handler A; Lobo MD; Alonso FJ; Paíno CL; Mena MA
    J Neurosci Res; 2000 May; 60(3):311-20. PubMed ID: 10797533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
    Hansson SR; Hoffman BJ; Mezey E
    Brain Res Dev Brain Res; 1998 Sep; 110(1):135-58. PubMed ID: 9733951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Caenorhabditis elegans to study vesicular transport.
    Rand JB; Duerr JS; Frisby DL
    Methods Enzymol; 1998; 296():529-47. PubMed ID: 9779472
    [No Abstract]   [Full Text] [Related]  

  • 11. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
    Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
    Weihe E; Schäfer MK; Erickson JD; Eiden LE
    J Mol Neurosci; 1994; 5(3):149-64. PubMed ID: 7654518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-independent cholinergic differentiation in the rat sympathetic nervous system.
    Schäfer MK; Schütz B; Weihe E; Eiden LE
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4149-54. PubMed ID: 9108120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental regulation of neurotransmitters in sympathetic neurons.
    Guidry GL; Landis SC
    Adv Pharmacol; 1998; 42():895-8. PubMed ID: 9328042
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter.
    Efange SM
    FASEB J; 2000 Dec; 14(15):2401-13. PubMed ID: 11099458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
    Frey KA; Wieland DM; Kilbourn MR
    Adv Pharmacol; 1998; 42():269-72. PubMed ID: 9327896
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional identification of vesicular monoamine and acetylcholine transporters.
    Varoqui H; Erickson JD
    Methods Enzymol; 1998; 296():84-99. PubMed ID: 9779442
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
    Hansson SR; Mezey E; Hoffman BJ
    Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of vesicular amine transporter function and targeting to secretory organelles.
    Erickson JD; Varoqui H
    FASEB J; 2000 Dec; 14(15):2450-8. PubMed ID: 11099462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H; Erickson JD
    J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.